(Q84927753)
Statements
Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects (English)
Titti Martinsson-Niskanen
Rikke Riisbro
Leonard Larsson
Lena Winstedt
Yvonne Stenberg
Steve Pakola
Jean-Marie Stassen
8 September 2011